Showing 1 - 7 of 7
when compared to global peers on pharmaceutical value-added, productivity, research and development and trade performance …
Persistent link: https://www.econbiz.de/10014200371
when compared to global peers on pharmaceutical value‐added, productivity, research and development and trade performance …
Persistent link: https://www.econbiz.de/10014207452
This study has analyzed the relative growth performance of Indian firms under the current economic slowdown and … the overall growth and stability of the global economy has become extremely important for the growth performance of Indian …
Persistent link: https://www.econbiz.de/10013153455
The liberalization of economic policies in the last two decades and intensifying market competition tend to be a cause of policy concern for the survival of SMEs in emerging economies like India. These SMEs account for the largest chunk of industrial units and employment in the national economy....
Persistent link: https://www.econbiz.de/10011524087
activities on the in‐house (domestic) R&D performance of Indian automotive firms during 1988–2008. As expected, the favourable …
Persistent link: https://www.econbiz.de/10014200376
In the present paper, it is attempted to empirically verify the impact of economic liberalization on the R&D behaviour of Indian pharmaceutical firms controlling for the effects of several firm specific characteristics including firm size. The results from the Tobit analysis for a sample of...
Persistent link: https://www.econbiz.de/10013153453
research on state-wise R&D performance of firms in India, this study serves an important contribution to the academic and …
Persistent link: https://www.econbiz.de/10013068772